Collagen Matrix Acquired by Private Equity Firm

By Julie A. Vetalice

Collagen Matrix Acquired by Private Equity Firm

Private equity firm Linden Capital Partners acquired Collagen Matrix, manufacturer of xenograft mineral- and collagen-based products used for tissue and bone repair and regeneration in orthopedic, sports medicine, dental and neurosurgery applications.

Collagen Matrix's portfolio includes SCC™ Synthetic Bone Grafts for orthopedics, OssiMend® bone graft products in various formats for orthopedics and spine, and TenoMend™ collagen wrap for tendon injuries.

Linden focuses exclusively on medical products, contract and private label manufacturing and the dental and orthopedic sectors. In January 2019, the firm acquired Avalign Technologies, a contract manufacturer of implants, instruments, cutting tools, specialty instruments and cases/trays.

Source: Linden Capital Partners

Tags: M&A